Cargando…
MKP-1 Deficiency Exacerbates Skin Fibrosis in a Mouse Model of Scleroderma
Scleroderma is a chronic fibrotic disease, where proinflammatory and profibrotic events precede collagen accumulation. MKP-1 [mitogen-activated protein kinase (MAPK) phosphatase-1] downregulates inflammatory MAPK pathways suppressing inflammation. MKP-1 also supports Th1 polarization, which could sh...
Autores principales: | Scotece, Morena, Hämäläinen, Mari, Leppänen, Tiina, Vuolteenaho, Katriina, Moilanen, Eeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002998/ https://www.ncbi.nlm.nih.gov/pubmed/36902103 http://dx.doi.org/10.3390/ijms24054668 |
Ejemplares similares
-
TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma
por: Mäki-Opas, Ilari, et al.
Publicado: (2023) -
Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients
por: Scotece, Morena, et al.
Publicado: (2020) -
Pinosylvin Shifts Macrophage Polarization to Support Resolution of Inflammation
por: Kivimäki, Konsta, et al.
Publicado: (2021) -
Widespread regulation of gene expression by glucocorticoids in chondrocytes from patients with osteoarthritis as determined by RNA-Seq
por: Pemmari, Antti, et al.
Publicado: (2020) -
IL-6 in Osteoarthritis: Effects of Pine Stilbenoids
por: Laavola, Mirka, et al.
Publicado: (2018)